SLANHEALTH

SLANHEALTH is an innovative digital healthcare application service platform in China that is data-driven and focuses on digital therapeutics. The "Hepatitis B Mother-to-Child Transmission Prevention" digital therapeutic developed by SLANHEALTH is the first digital therapeutic product in China to receive NMPA certification. Based on customer needs, SLANHEALTH provides research and development, market entry, operation, scientific research, and data processing services for digital therapeutics products in China with higher efficiency and lower cost. At the same time, through wearable devices, physiological and behavioral data generated by users in non-hospital or home environments are collected. Combined with AI to deeply explore the relationship between data and diseases, digital biomarkers are discovered. Based on the SaaS platform and modular R&D model, digital healthcare products centered on digital therapeutics are efficiently developed, and comprehensive health solutions with full-process services are provided.